Wellbutrin sr and Phoslo drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Wellbutrin sr (bupropion hydrochloride) and Phoslo (calcium acetate). Common drug interactions include injury among females and pain among males.

The phase IV clinical study analyzes what interactions people have when they take Wellbutrin sr and Phoslo. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Wellbutrin sr?

Wellbutrin sr has active ingredients of bupropion hydrochloride. It is often used in depression. eHealthMe is studying from 13,112 Wellbutrin sr users. Check the latest studies of Wellbutrin sr.

What is Phoslo?

Phoslo has active ingredients of calcium acetate. eHealthMe is studying from 4,291 Phoslo users. Check the latest studies of Phoslo.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 15, 2026

13 people who take Wellbutrin sr and Phoslo together, and have interactions are studied.

Wellbutrin sr and Phoslo drug interactions.

What are the common drug interactions of Wellbutrin Sr and Phoslo, by gender? *:

female:

  1. Injury
  2. Myofascial pain syndrome (a painful condition that affects the muscles and the sheath of the tissue)
  3. Oedema peripheral (superficial swelling)
  4. Osteomyelitis (infection of bone)
  5. Pain
  6. Spinal osteoarthritis (joint cartilage loss in spine)
  7. Submandibular mass
  8. Apheresis
  9. Hypokalaemia (low potassium)
  10. Tooth extraction

male:

  1. Pain
  2. Therapeutic response unexpected
  3. Weight decreased
  4. Abasia (inability to walk)

What are the common drug interactions of Wellbutrin Sr and Phoslo, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Hypercalcaemia (elevated calcium (ca+) level in the blood)
  2. Hypoaesthesia (reduced sense of touch or sensation)
  3. Hypokalaemia (low potassium)
  4. Impaired healing
  5. Injury
  6. Intervertebral disc degeneration (spinal disc degeneration)
  7. Intervertebral disc protrusion (spinal disc protrusion)
  8. Musculoskeletal pain (pain affects the bones, muscles, ligaments, tendons, and nerves)
  9. Myeloma recurrence (recurrence of cancer of the plasma cells - a kind of white blood cell)
  10. Myofascial pain syndrome (a painful condition that affects the muscles and the sheath of the tissue)

40-49:

  1. Alpha haemolytic streptococcal infection (infections with alpha-haemolytic strep bacteria are common; many strains live naturally in humans)
  2. Anaemia (lack of blood)
  3. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  4. Disability
  5. Fistula discharge (discharge from abnormal passage of structure/organ)
  6. Injury
  7. Myofascial pain syndrome (a painful condition that affects the muscles and the sheath of the tissue)
  8. Osteomyelitis (infection of bone)
  9. Pain
  10. Spinal osteoarthritis (joint cartilage loss in spine)

50-59:

  1. Pain
  2. Therapeutic response unexpected
  3. Weight decreased
  4. Abasia (inability to walk)

60+:

  1. Abdominal discomfort
  2. Abdominal pain
  3. Dehydration (dryness resulting from the removal of water)
  4. Delirium (wild excitement)
  5. Diastolic dysfunction
  6. Dizziness
  7. Dyspnoea (difficult or laboured respiration)
  8. Dyspnoea paroxysmal nocturnal (respiratory distress that awakens patients from sleep)
  9. Ecchymosis (a discoloration of the skin resulting from bleeding underneath)
  10. Fluid overload (too much fluid in the blood)

What are the existing conditions these people have? *

  1. Pain: 6 people, 46.15%
  2. Multiple Myeloma (cancer of the plasma cells): 6 people, 46.15%
  3. Vitamin B1 Deficiency: 5 people, 38.46%
  4. Neuropathy Peripheral (surface nerve damage): 5 people, 38.46%
  5. Nerve Injury: 5 people, 38.46%
  6. Joint Pain: 5 people, 38.46%

* Approximation only. Some reports may have incomplete information.

Do you take Wellbutrin sr and Phoslo?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Wellbutrin sr and Phoslo:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Wellbutrin sr:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Phoslo:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Wellbutrin sr and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Phoslo and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on bupropion hydrochloride and calcium acetate (the active ingredients of Wellbutrin sr and Phoslo, respectively), and Wellbutrin sr and Phoslo (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: